Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.31 | N/A | +3.56% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.31 | N/A | +3.56% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting a commitment to future growth. However, they did not provide specific revenue guidance.
We are pleased with our EPS performance this quarter.
While we did not provide revenue figures, we remain focused on our long-term growth strategies.
Agilent Technologies reported a positive surprise in EPS, which contributed to a slight increase in stock price by 0.22%. The lack of revenue figures and guidance leaves some uncertainty, but management's positive tone suggests confidence in future performance. Investors may view the EPS beat as a sign of operational strength.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
PUBLIC STORAGE REIT
Feb 24, 2025